1. Prognostic value of quality-of-life scores in patients with breast cancer undergoing preoperative chemotherapy
    K. Takada et al, 2019, BJS Open CrossRef
  2. Clinical verification of body mass index and tumor immune response in patients with breast cancer receiving preoperative chemotherapy
    Koji Takada et al, 2021, BMC Cancer CrossRef
  3. Differences in tumor-infiltrating lymphocyte density and prognostic factors for breast cancer by patient age
    Koji Takada et al, 2022, World Journal of Surgical Oncology CrossRef
  4. Prognostic significance of pathological complete response following neoadjuvant chemotherapy for operable breast cancer
    HIDEMI KAWAJIRI et al, 2014, Oncology Letters CrossRef
  5. Clinical verification of the relationship between smoking and the immune microenvironment of breast cancer
    Koji Takada et al, 2019, Journal of Translational Medicine CrossRef

  6. Pathologic Response After Weekly Paclitaxel versus Docetaxel in Operable Breast Cancer


    Xenia Elena Bacinschi et al, 2020, Cancer Management and Research CrossRef
  7. Possibility of avoiding axillary lymph node dissection by immune microenvironment monitoring in preoperative chemotherapy for breast cancer
    Koji Takada et al, 2018, Journal of Translational Medicine CrossRef
  8. Neoadjuvant Therapy with Concurrent Docetaxel, Epirubicin, and Cyclophosphamide (TEC) in High-Risk HER2-Negative Breast Cancers
    Bryan Li et al, 2021, Advances in Therapy CrossRef
  9. Significance of re-biopsy for recurrent breast cancer in the immune tumour microenvironment
    Koji Takada et al, 2018, British Journal of Cancer CrossRef
  10. Novel evaluation scale for QOL (QOL-ACD-BP) in preoperative chemotherapy for breast cancer
    Koji Takada et al, 2018, Journal of Cancer Research and Clinical Oncology CrossRef
  11. Clinical verification of sensitivity to preoperative chemotherapy in cases of androgen receptor-expressing positive breast cancer
    Yuka Asano et al, 2016, British Journal of Cancer CrossRef